Standard-dose osimertinib for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancer
Standard-dose osimertinib for refractory leptomeningeal metastases in T790M-positive <i>EGFR</i>-mutant non-small cell lung cancer, Published online: 30 November 2017; doi:10.1038/bjc.2017.394
Standard-dose osimertinib for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancer
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2irtg65
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,